FENC Q2 2025 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$220M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+32.9% YoY

Gross Profit

$9M90.0% margin

Operating Income

-$3M-28.3% margin

Net Income

-$3M-32.7% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$45M

Total Liabilities

$52M

Stockholders' Equity

-$7M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+32.9%
Gross Profit	$9M	$7M	+30.5%
Operating Income	-$3M	-$5M	+45.8%
Net Income	-$3M	-$6M	+43.2%